164 related articles for article (PubMed ID: 1515974)
1. A prospective randomized controlled trial of sandostatin and vasopressin in the management of acute bleeding esophageal varices.
Huang CC; Sheen IS; Chu CM; Chuah SK; Chien RN; Peng SM; Kuo YC; Lin SM; Lin DY; Chen PC
Changgeng Yi Xue Za Zhi; 1992 Jun; 15(2):78-83. PubMed ID: 1515974
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding.
Hwang SJ; Lin HC; Chang CF; Lee FY; Lu CW; Hsia HC; Wang SS; Lee SD; Tsai YT; Lo KJ
J Hepatol; 1992 Nov; 16(3):320-5. PubMed ID: 1487608
[TBL] [Abstract][Full Text] [Related]
3. Sandostatin therapy of acute oesophageal variceal bleeding.
McKee RF
Digestion; 1993; 54 Suppl 1():27-9. PubMed ID: 8359565
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive Agents for the Management of Variceal Bleeding: A Mixed Treatment Comparison Network Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials.
Sridharan K; Sivaramakrishnan G
Drug Res (Stuttg); 2019 Sep; 69(9):487-495. PubMed ID: 30776840
[TBL] [Abstract][Full Text] [Related]
5. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage.
Seo YS; Park SY; Kim MY; Kim JH; Park JY; Yim HJ; Jang BK; Kim HS; Hahn T; Kim BI; Heo J; An H; Tak WY; Baik SK; Han KH; Hwang JS; Park SH; Cho M; Um SH
Hepatology; 2014 Sep; 60(3):954-63. PubMed ID: 24415445
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study.
Zhou Y; Qiao L; Wu J; Hu H; Xu C
J Gastroenterol Hepatol; 2002 Sep; 17(9):973-9. PubMed ID: 12167118
[TBL] [Abstract][Full Text] [Related]
7. Octreotide or vasopressin for bleeding esophageal varices.
Law AW; Gales MA
Ann Pharmacother; 1997 Feb; 31(2):237-8. PubMed ID: 9034426
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized controlled clinical trial comparing the effects of somatostatin and vasopressin for control of acute variceal bleeding in the patients with liver cirrhosis.
Lee HY; Lee HJ; Lee SM; Kim JH; Kweon SW; Lee BS; Kim NJ
Korean J Intern Med; 2003 Sep; 18(3):161-6. PubMed ID: 14619385
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage.
Kravetz D; Bosch J; Terés J; Bruix J; Rimola A; Rodés J
Hepatology; 1984; 4(3):442-6. PubMed ID: 6144625
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized trial from Turkey comparing octreotide versus injection sclerotherapy in acute variceal bleeding.
Sivri B; Oksuzoglu G; Bayraktar Y; Kayhan B
Hepatogastroenterology; 2000; 47(31):168-73. PubMed ID: 10690604
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin in acute bleeding oesophageal varices. Clinical evidence.
Jenkins SA
Drugs; 1992; 44 Suppl 2():36-55; discussion 70-2. PubMed ID: 1385069
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage.
Imperiale TF; Teran JC; McCullough AJ
Gastroenterology; 1995 Oct; 109(4):1289-94. PubMed ID: 7557097
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of vasopressin/terlipressin and somatostatin/octreotide for the prevention of early variceal rebleeding after the initial control of bleeding: a systematic review and meta-analysis.
Wang C; Han J; Xiao L; Jin CE; Li DJ; Yang Z
Hepatol Int; 2015 Jan; 9(1):120-9. PubMed ID: 25788386
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis: vasoactive medications for the management of acute variceal bleeds.
Wells M; Chande N; Adams P; Beaton M; Levstik M; Boyce E; Mrkobrada M
Aliment Pharmacol Ther; 2012 Jun; 35(11):1267-78. PubMed ID: 22486630
[TBL] [Abstract][Full Text] [Related]
15. Is somatostatin effective in the treatment of acute bleeding caused by esophageal varices?
Mezick SL; Henderson RP
Ann Pharmacother; 1994 Jun; 28(6):739-40. PubMed ID: 7919564
[No Abstract] [Full Text] [Related]
16. A controlled study of glypressin versus vasopressin in the control of bleeding from oesophageal varices.
Chiu KW; Sheen IS; Liaw YF
J Gastroenterol Hepatol; 1990; 5(5):549-53. PubMed ID: 1966593
[TBL] [Abstract][Full Text] [Related]
17. Octreotide in acute bleeding esophageal varices: a prospective randomized study.
Freitas DS; Sofia C; Pontes JM; Gregório C; Cabral JP; Andrade P; Rosa A; Camacho E; Ferreira M; Portela F; Romãozinho JM; Tomé L; Gouveia H; Leitão M; Pimenta I; Donato A
Hepatogastroenterology; 2000; 47(35):1310-4. PubMed ID: 11100339
[TBL] [Abstract][Full Text] [Related]
18. Comparison of somatostatin and vasopressin in bleeding esophageal varices.
Saari A; Klvilaakso E; Inberg M; Pääkkönen M; Lahtinen J; Höckerstedt K; Schröder T
Am J Gastroenterol; 1990 Jul; 85(7):804-7. PubMed ID: 1973591
[TBL] [Abstract][Full Text] [Related]
19. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial.
Abid S; Jafri W; Hamid S; Salih M; Azam Z; Mumtaz K; Shah HA; Abbas Z
Am J Gastroenterol; 2009 Mar; 104(3):617-23. PubMed ID: 19223890
[TBL] [Abstract][Full Text] [Related]
20. Use of octreotide in the acute management of bleeding esophageal varices.
Sadowski DC
Can J Gastroenterol; 1997; 11(4):339-43. PubMed ID: 9218860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
